Pharmaceutical Executive-05-01-2022

The importance of equitable approaches to diagnosis and treatment.

Biopharma experts at the forefront of applying real-world data and real-world evidence across the product life cycle converge to discuss the lingering challenges in fully realizing the vast potential of these insights to transform the value equation.

With lessons and perspectives from the field, the importance of harnessing the right combination of skills to advance up and across career ladders is explored.

The stages of a career well-spent in advancing healthcare innovation.

Amid pandemic, leader helps build ‘commercial startup’ from the ground up.

Using edutainment to capture audiences and break down complex medical information.

An entrepreneurial quest to transform oncology treatment.

‘Whole self’ approach to life and leadership keys passion for helping patients.

Motivated by forging new—and needed—pathways in drug development.

A storied climb from chemist, to Middle East sales rep, to master of product launch.

Fast riser in biotech strategy execution seizes on opportunities in immunotherapy.

Physician-scientist turned Big Pharma medical chief sees fruits of labor.

Tenacious drive to reach patients characterizes career.

How an early personal realization in healthcare focus paved path for greater impact.

Pharm Exec profiles its 2022 Emerging Pharma Leaders.

Living to fight another day, as potential investment spark looms.

With more promising products emerging, investment risks remain.

Instead, incorporate ESG into your long-term business planning.

The risky business of outmaneuvering Europe’s drug pricing authorities.

Pharm Exec announces annual Emerging Pharma Leaders class.

Click the title above for a link to open the Pharmaceutical Executive May 2022 issue in an interactive PDF format.

Transition likely with looming end to emergency use authorizations tied to COVID-19 pandemic.